ASX - By Stock
|
GTG |
Re:
Ann: COVID- 19 Risk Test Approved for Commercial Release
|
|
Londonstill
|
15 |
8.0K |
1 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
15
|
8.0K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
|
|
Londonstill
|
31 |
15K |
5 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
31
|
15K
|
5
|
|
ASX - By Stock
|
GTG |
Re:
Ann: GTG Secures US and ANZ Distribution Rights for PREDICTIX
|
|
Londonstill
|
27 |
12K |
2 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
27
|
12K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Ann: GTG Secures US and ANZ Distribution Rights for PREDICTIX
|
|
Londonstill
|
27 |
12K |
7 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
27
|
12K
|
7
|
|
ASX - By Stock
|
GTG |
Re:
GTG to Hold Investor Webinar and Q&A Session on November 19
|
|
Londonstill
|
12 |
4.9K |
4 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
12
|
4.9K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Genetype for breast cancer up for sale via telehealth In US
|
|
Londonstill
|
37 |
10K |
8 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
37
|
10K
|
8
|
|
ASX - By Stock
|
GTG |
Re:
Genetype for breast cancer up for sale via telehealth In US
|
|
Londonstill
|
37 |
10K |
1 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
37
|
10K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
Genetype for breast cancer up for sale via telehealth In US
|
|
Londonstill
|
37 |
10K |
12 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
37
|
10K
|
12
|
|
ASX - By Stock
|
GTG |
Re:
Genetype for breast cancer up for sale via telehealth In US
|
|
Londonstill
|
37 |
10K |
6 |
05/09/20 |
05/09/20 |
ASX - By Stock
|
37
|
10K
|
6
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Nasdaq Compliance Confirmation
|
|
Londonstill
|
1 |
933 |
4 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
1
|
933
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Beijing beat us to it
|
|
Londonstill
|
2 |
762 |
6 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
2
|
762
|
6
|
|
ASX - By Stock
|
GTG |
Re:
Genetype for breast cancer up for sale via telehealth In US
|
|
Londonstill
|
37 |
10K |
0 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
37
|
10K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Genetype for breast cancer up for sale via telehealth In US
|
|
Londonstill
|
37 |
10K |
1 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
37
|
10K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
Genetype for breast cancer up for sale via telehealth In US
|
|
Londonstill
|
37 |
10K |
4 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
37
|
10K
|
4
|
|
ASX - By Stock
|
GTG |
Genetype for breast cancer up for sale via telehealth In US
|
|
Londonstill
|
37 |
10K |
16 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
37
|
10K
|
16
|
|
ASX - By Stock
|
GTG |
Re:
News: GTG Genetic Technologies Files Provisional Patent For Its COVID-19 Severity Risk Test With...
|
|
Londonstill
|
46 |
15K |
6 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
46
|
15K
|
6
|
|
ASX - By Stock
|
GTG |
Re:
News: GTG Genetic Technologies Files Provisional Patent For Its COVID-19 Severity Risk Test With...
|
|
Londonstill
|
46 |
15K |
2 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
46
|
15K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Ann: US Patent Office Grants Key Risk Test Patent
|
|
Londonstill
|
52 |
13K |
4 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
52
|
13K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Ann: US Patent Office Grants Key Risk Test Patent
|
|
Londonstill
|
52 |
13K |
5 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
52
|
13K
|
5
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Genetic Technologies Announces USD 8 Million capital raising
|
|
Londonstill
|
43 |
11K |
4 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
43
|
11K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Ann: JP Morgan Biotech Showcase Investor Presentation
|
|
Londonstill
|
41 |
32K |
9 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
41
|
32K
|
9
|
|
ASX - By Stock
|
GTG |
Re:
Nasdaq filing
|
|
Londonstill
|
17 |
18K |
3 |
25/08/19 |
25/08/19 |
ASX - By Stock
|
17
|
18K
|
3
|
|
ASX - By Stock
|
GTG |
Re:
Nasdaq filing
|
|
Londonstill
|
17 |
18K |
2 |
19/08/19 |
19/08/19 |
ASX - By Stock
|
17
|
18K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Response to ASX Query
|
|
Londonstill
|
32 |
12K |
3 |
12/06/19 |
12/06/19 |
ASX - By Stock
|
32
|
12K
|
3
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Response to ASX Query
|
|
Londonstill
|
32 |
12K |
4 |
11/06/19 |
11/06/19 |
ASX - By Stock
|
32
|
12K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Pause in Trading
|
|
Londonstill
|
43 |
18K |
0 |
24/05/19 |
24/05/19 |
ASX - By Stock
|
43
|
18K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Pause in Trading
|
|
Londonstill
|
43 |
18K |
1 |
24/05/19 |
24/05/19 |
ASX - By Stock
|
43
|
18K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
GTGs biggest problem
|
|
Londonstill
|
5 |
3.4K |
12 |
13/05/19 |
13/05/19 |
ASX - By Stock
|
5
|
3.4K
|
12
|
|
ASX - By Stock
|
GTG |
Re:
Ann: New Product Announcement
|
|
Londonstill
|
127 |
47K |
3 |
13/05/19 |
13/05/19 |
ASX - By Stock
|
127
|
47K
|
3
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Lapse of Employee Options 9 April 2019
|
|
Londonstill
|
3 |
1.7K |
2 |
10/04/19 |
10/04/19 |
ASX - By Stock
|
3
|
1.7K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Ann: TGen MoU Accouncement
|
|
Londonstill
|
11 |
4.1K |
4 |
08/04/19 |
08/04/19 |
ASX - By Stock
|
11
|
4.1K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Buy order
|
|
Londonstill
|
50 |
17K |
4 |
17/01/19 |
17/01/19 |
ASX - By Stock
|
50
|
17K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
3 |
19/12/18 |
19/12/18 |
ASX - By Stock
|
301
|
125K
|
3
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
1 |
14/12/18 |
14/12/18 |
ASX - By Stock
|
301
|
125K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
5 |
27/11/18 |
27/11/18 |
ASX - By Stock
|
301
|
125K
|
5
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Lodgement Prospectus and Appendix 3B
|
|
Londonstill
|
10 |
5.7K |
6 |
19/11/18 |
19/11/18 |
ASX - By Stock
|
10
|
5.7K
|
6
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
0 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
301
|
125K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
3 |
15/11/18 |
15/11/18 |
ASX - By Stock
|
301
|
125K
|
3
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
4 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
301
|
125K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
3 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
301
|
125K
|
3
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Change to CEO's Remuneration
|
|
Londonstill
|
15 |
6.1K |
4 |
10/11/18 |
10/11/18 |
ASX - By Stock
|
15
|
6.1K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Ann: US Annual Report on Form 20-F
|
|
Londonstill
|
8 |
3.9K |
3 |
03/11/18 |
03/11/18 |
ASX - By Stock
|
8
|
3.9K
|
3
|
|
ASX - By Stock
|
GTG |
Re:
Ann: US Annual Report on Form 20-F
|
|
Londonstill
|
8 |
3.9K |
0 |
02/11/18 |
02/11/18 |
ASX - By Stock
|
8
|
3.9K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
2 |
01/11/18 |
01/11/18 |
ASX - By Stock
|
301
|
125K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
2 |
31/10/18 |
31/10/18 |
ASX - By Stock
|
301
|
125K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
2 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
301
|
125K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
0 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
301
|
125K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
2 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
301
|
125K
|
2
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
1 |
29/10/18 |
29/10/18 |
ASX - By Stock
|
301
|
125K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
Announcment!
|
|
Londonstill
|
301 |
125K |
0 |
29/10/18 |
29/10/18 |
ASX - By Stock
|
301
|
125K
|
0
|
|